Hypha Labs (FUNI) Net Equity Issued and Repurchased (2012 - 2024)

Hypha Labs' (FUNI) quarterly Net Equity Issued and Repurchased came in at $100.0 in Q4 2024, down 99.51% on a QoQ basis from $20250.0 in Q4 2020.

Hypha Labs (FUNI) Net Equity Issued and Repurchased (2012 - 2024) Analysis & Trends

Hypha Labs (FUNI) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $100.0 in Q4 2024.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $100.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $100.0 (changed N/A YoY) and the FY2022 annual result came in at $55600.0, up 174.57% from the prior year.
Net Equity Issued and Repurchased retreated to $100.0 in Q4 2024, from $20250.0 in the prior quarter.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $20250.0 in Q4 2020 to a low of $100.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	-
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	-
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	-
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	-
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	-
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	-
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	-
10	Hypha Labs	2.26 Mn	2.18 Mn	-	-

Download Data